Sysbiz Technologies | Major Global Life Science Company to Go Live on BPI’s GTN Revenue Recognition (R2) Product
15232
post-template-default,single,single-post,postid-15232,single-format-standard,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-16.9,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.5.5,vc_responsive

Major Global Life Science Company to Go Live on BPI’s GTN Revenue Recognition (R2) Product

Having gone live on January 1st, 2011 with BPI’s GTN R2 product, Novartis-Alcon is now entering its 36th month of valuable business return. In the meantime, another global lifescience manufacture has been working with BPI to enhance BPI’s initial GTN offering to include extensive forecasting capabilities, pricing ‘what-if’ capabilities, AdHoc reporting, and numerous other major enhancements to make BPI the only proven GTN automation product provider. With its GTN best practice industry group and alliances, BPI’s GTN end-to-end product provides its customers with GTN best practice functionality including extensive workflow capabilities that reduce regulatory risk and financial close accuracy and time.